Live Science on MSNOpinion
One molecule could usher revolutionary medicines for cancer, diabetes and genetic disease — but the US is turning its back on it
The U.S. government is divesting from mRNA vaccines, but will other uses of the technology be spared? In a time of ...
Joe Scott on MSN
How Scientists Actually Use Gene Editing to Fight Cancer
How can altering DNA help defeat one of the world’s deadliest diseases? This video explores how scientists are using CRISPR ...
Both CRSP and NTLA are advancing in vivo gene editing therapies targeting large markets, with financial stability supporting ...
Gene editing techniques, including CRISPR, prime editing, and nucleases, allow scientists to tackle genetic diseases, cancer, ...
Researchers at Memorial Sloan Kettering Cancer Center (MSK) have developed some of the first robust laboratory models of a ...
4don MSN
Naked Mole Rats: The tiny creatures unlocking the future of cancer treatment and fertility control
Unlocking secrets from East Africa's naked mole rats, scientists are amazed by their cancer immunity and unique social ...
We have the tech to make designer babies but we are not ready for it yet. Read more at straitstimes.com. Read more at straitstimes.com.
Seven years after the first gene-edited babies were revealed, biotech startup Manhattan Genomics is reviving the idea of ...
News-Medical.Net on MSN
Epigenetic editing enables safer and more effective T cell therapies
Arc Institute, Gladstone Institutes, and University of California, San Francisco, scientists have developed an epigenetic ...
Over the past two decades, synthetic biology has fueled advancements across a broad range of disciplines, including agriculture, bioremediation, biofuel production, and chemical manufacturing. Today, ...
MIT scientists have found a way to make gene editing far safer and more accurate — a breakthrough that could reshape how we treat hundreds of genetic diseases. By fine-tuning the tiny molecular “tools ...
In a significant turn of events, Intellia Therapeutics has announced the temporary suspension of dosing and patient screening in two late-stage studies of its groundbreaking gene-editing treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results